American Head & Neck Society

Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.

American Head & Neck Society | AHNS


The mission of the AHNS is to advance Education, Research, and Quality of Care for the head and neck oncology patient.

  • About
    • Mission Statement and Purpose
    • Divisions & Services of the Society
      • Education
        • Scientific Program/Resident Courses
        • Surgical Videos
        • Journal Club
        • Journals
        • Global Outreach
        • Awards
          • Margaret F. Butler Award
      • Diversity, Equity and Inclusion Division
      • Patient Care
        • Cancer Survivorship
          • Patient Education on Post-Treatment Care
          • Interviews with Cancer Survivors
        • Cancer Prevention
          • SLIDE DECK: HPV-Related Oropharyngeal Cancer
        • Guidelines/Position Statements
        • Find-A-Physician
      • Research
        • Grant Information
        • Clinical Trial
        • Tissue Banks
      • Administrative Divison
        • Development Service Process for Evaluating Projects Requiring Funding
    • Leadership
    • History
      • Society Background
      • AHNS History Interviews
      • Past Presidents
      • In Memory
    • AHNS Newsletter
    • Professionalism & Ethics
    • AHNS Policies and Procedures (P&P) Manual
    • AHNS Foundation
    • AHNS Bylaws
    • AHNS Staff
    • AHNS News and Announcements
    • COVID-19 Bulletin Board
  • Heads Up!
  • Post a Job
  • Meetings
    • AHNS Virtual Education Series
      • TORS Webinar Series
    • AHNS Meetings Info
    • AHNS Call For Abstracts
    • AHNS Call For Late Breaking Abstracts
    • Exhibitor and Support Opportunities
    • Past Meetings
    • Related Meetings
  • For Patients
  • For Trainees
    • Accredited Fellowships
      • Fellowship Match
      • Directory of Fellowships
      • Fellowship Curriculum
      • Certificate of Completion Request
      • Fellowship Graduates
      • For Program Directors
      • For Current AHNS Fellows
    • AHNS Surgical Videos
    • Fellows’ Virtual Tumor Boards
    • Cutaneous Cancer
  • Sections
    • Endocrine Surgery
    • Skull Base Surgery Section
    • Reconstructive Head & Neck Surgery
    • Mucosal Malignancy Section
      • Mucosal Malignancy Section Patient Information
    • Salivary Gland
    • Cutaneous Cancer
  • Member Central
    • Join AHNS
    • Find-A-Physician
    • Mailing List Order
  • Log In
  • Donate

Use of PD-1 Inhibitors in Treating Advanced (cSCC) – Survey

AHNS Consensus Statement on the Use of PD-1 Inhibitors in Treating Advanced Cutaneous Squamous Cell Carcinoma (cSCC)

Cecelia E. Schmalbach, MD, MSc
Karen Choi, MD
Kevin Emerick, MD
Brian Haughley, MD
Scott McLean, MD, PhD
Brian Moore, MD
Miriam O’Leary, MD
T.J. Ow, MD 

Primary Survey Goal: The United States Federal Drug Administration (FDA) approved the use of PD-1 inhibitors Cemiplimab and Pembrolizumab to treat advanced cutaneous squamous cell carcinoma (cSCC).  A consensus statement put forth by the American Head and Neck Society (AHNS) is required in order to ensure the highest level of evidence based care to our patients.

The statements below were collated following a comprehensive review of the literature to include clinical trials and position statements put forth by our sister societies such as  medical and radiation oncology.  The draft underwent 4 cycles of review for clarity and consistency with senior leadership in the AHNS Cutaneous Cancer Section.   A medical oncologist and radiation oncologist affiliated with the AHNS then reviewed it.

We need your voice  in order to publish an impactful AHNS consensus statement.  Please click the link below and take 5 minutes to share your level of agreement on the presented statements.  A score of 7 and above will be considered as agreement.

Thank you in advance for your time,
Cecelia E. Schmalbach, MD, MSc

Click Here To Take The Survey

Share:

  • Facebook
  • Twitter
  • LinkedIn

Contact Us

AHNS, 11300 W. Olympic Blvd, Suite 600
Los Angeles, CA 90064
ph: (310) 437-0559 / fx: (310) 437-0585
[email protected]

Search this website

Follow the AHNS

  • Email
  • Facebook
  • Twitter
  • YouTube

Recent Heads Up! Posts

AHNS 2023 Meeting – Late Breaking Call For Abstracts – Final Day To Submit Abstracts

ARS NASBS AHNS Sinonasal Cancer Collaborative – Sinonasal Malignancy Virtual Tumor Board

AHNS 2023 Meeting – Late Breaking Call For Abstracts – 1 Week Left To Submit Abstracts

More News and Announcements

© 2002–2023 American Head and Neck Society · Privacy and Return Policy
· Managed by BSC Management, Inc